Dr. Abdul R h Mamsa M.D

Recommended Articles

• Lemtrada Gains FDA Approval to Treat Multiple Sclerosis

  In the United States alone, over 400,000 individuals are dealing with the challenges associated with multiple sclerosis (MS). Most recently, Sanofi, an international leader in healthcare, announced FDA approval of the prescription drug Lemtrada, for the treatment of patients with relapsing forms of...

• What Are the Symptoms of Cold Sores?

  What are cold sores?Cold sores or fever blisters are a very common perioral condition caused by the herpes simplex virus (HSV). There are two types of herpes simplex virus. Type 1 usually causes cold sores, although in some cases, the cold sores can also be caused by type 2. It is usually...

• Depression Leads to Non-Adherence of COPD Medication

  Chronic obstructive pulmonary disease (COPD) is a progressive disease, which currently does not have a cure yet, as modern medicine has not found a way to reverse the damage done to the airways and lungs. For this reason, there is a slow and long-term development of debilitating symptoms. The...

• How Is Sarcoidosis Diagnosed?

  What is sarcoidosis?Sarcoidosis is an inflammatory disease, which is characterized by the growth of granulomas or tiny collections of inflammatory cells in various parts of the body. When the immune system is slowed down and when these numerous clumps form, they tend to interfere with the organ’s...

• What Is Insomnia? Get the Facts

  Insomnia is also known as sleeplessness. It is a sleep disorder where people have trouble sleeping. Insomnia is caused by several factors. People with insomnia have abnormal sleeping patterns as well as daytime sleepiness, irritability, and a depressed mood. They may also have an increased...

• What Does 'Benign' Multiple Sclerosis Mean?

  Benign multiple sclerosis (MS) is not a term that is used too frequently when talking about this neurological disorder. The definition of benign MS and what it specifically means is something that has been an area of contention in the medical community.In October of 2017 Multiple Sclerosis News...